NYC-based Superstring Capital is a financial services and venture capital firm.
6
Operating
2019
New York City, NY, US
Superstring Capital is a New York City-based venture capital firm focusing on late-stage investments in the biotech and pharmaceutical sectors. The firm typically participates in Series B and Series C funding rounds, with investments ranging from $50 million to $170 million.
Notable portfolio companies include AffaMed Therapeutics, ReCode Therapeutics, and Shoreline Biosciences. Superstring Capital's investment strategy appears to target companies developing innovative therapeutics and biotechnologies. The firm likely provides strategic guidance and industry connections to support its portfolio companies' growth and development in the competitive life sciences sector.
Portfolio Snapshot
Portfolio activity breakdown across disclosed investments and stages
Portfolio Companies5
Current Portfolio Count5
Top Investment Stages
Series B3 (75.0%)
Series C1 (25.0%)
Stage Mix
Series B 75%Series C 25%
Concentration shown as share of disclosed investments by stage.